MYL12B: A Potential Drug Target and Biomarker (G103910)

Target Name: MYL12B

NCBI ID: G103910

MYL12B

MYL12B: A Potential Drug Target and Biomarker

Myosin light chain 12B (MYL12B) is a protein that is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key regulator of muscle growth and function and is often used as a drug target or biomarker. In this article, we will discuss the research on MYL12B and its potential as a drug target.

MYL12B as a Drug Target

MYL12B has been identified as a potential drug target due to its involvement in muscle contraction and relaxation. Studies have shown that inhibiting MYL12B can lead to muscle relaxation and an improvement in muscle function. This has led to the idea that MYL12B could be a useful target for drugs that are designed to improve muscle function.

One of the main reasons for the potential of MYL12B as a drug target is its role in regulating muscle growth and development.MYL12B is a key regulator of muscle myosin filament assembly and disassembly, which is critical for muscle growth and development. It has been shown that inhibiting MYL12B can lead to a reduction in muscle size and an improvement in muscle function.

Another reason for the potential of MYL12B as a drug target is its role in pain perception.MYL12B has been shown to be involved in the regulation of pain perception and has been linked to the development of chronic pain. inhibiting MYL12B has been shown to improve pain perception in animal models of pain.

MYL12B as a Biomarker

MYL12B has also been identified as a potential biomarker for a variety of diseases.MYL12B has been shown to be expressed in a variety of tissues, including muscle, heart, and brain, and has been used as a biomarker for a variety of diseases. It has been shown to be involved in the development of certain diseases, such as cancer, heart disease, and neurodegenerative diseases.

MYL12B has also been shown to be involved in the regulation of cellular processes, including cell signaling and protein synthesis. It has been shown to play a role in the regulation of cell proliferation and has been linked to the development of certain diseases.

Conclusion

In conclusion, MYL12B is a protein that is expressed in muscle cells and is involved in muscle contraction and relaxation. It has been identified as a potential drug target due to its involvement in muscle growth and development, pain perception, and cellular processes. Further research is needed to fully understand the potential of MYL12B as a drug target and biomarker.

Protein Name: Myosin Light Chain 12B

Functions: Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Phosphorylation triggers actin polymerization in vascular smooth muscle. Implicated in cytokinesis, receptor capping, and cell locomotion

The "MYL12B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYL12B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets